The 6.5 acre site was acquired from German pharmaceutical company Boehringer Ingelheim. The acquisition means that V Park will now be able to accommodate up to 400,000 sq ft of urban logistics and light industrial development.
The 6.5 acre site was acquired from German pharmaceutical company Boehringer Ingelheim. The acquisition means that V Park will now be able to accommodate up to 400,000 sq ft of urban logistics and light industrial development.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In